Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Oasmia announces that the extraordinary general meeting 25 January 2019 is cancelled

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jan 2019
Related companies:  Oasmia Pharmaceutical AB

Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Advanced Hepatocellular Carcinoma in Frontiers in Oncology

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jan 2019
Related companies:  Immunicum AB

BerGenBio Announces Start of Phase I Trial Evaluating ADCT-601, a Novel Anti-AXL ADC, in Patients With Advanced Solid Tumours

BERGEN, Norway, Jan. 21, 2019 /PRNewswire/ -- BerGenBio ASA (OSE:BGBIO), announces that the first patient has been dosed in a phase I clinical trial evaluating the safety, tolerability, pharmacokinetics and anti-tumour efficacy of ADCT-601, an AXL-targeting antibody drug conjugate (ADC), in patients... Read more ››

By: PR Newswire Association LLC. - 21 Jan 2019
Related companies:  BerGenBio ASA

Targovax is Invited to Present at Upcoming Investor Conferences

OSLO, Norway, Jan. 21, 2019 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces that members of its senior management team will present at upcoming investor conferences.

Read more ››
By: PR Newswire Association LLC. - 21 Jan 2019
Related companies:  Targovax ASA

Caplin Steriles Announces INR 218 Crore Investment by Eight Roads Ventures and F-Prime Capital

MUMBAI, January 21, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Jan 2019

ESA and GomSpace Sign Contract for Advanced Nanosatellite to Join the HERA Mission

STOCKHOLM, Jan. 21, 2019 /PRNewswire/ -- GomSpace and ESA have signed a contract to develop a 6U nanosatellite, named Juventas to join the HERA mission. The Juventas nanosatellite will perform scientific tasks and eventual land on the Didymoon asteroid. The contract value is 400.000 €.

... Read more ››
By: PR Newswire Association LLC. - 21 Jan 2019

Spectrum Biomedical UK Opens New Chapter for Medicinal Cannabis Industry

OXFORD, England, January 21, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Jan 2019

Artificial Intelligence Helps Antwerp University Hospital Radiologists Save Lives

The Antwerp University Hospital radiology department uses Aidoc's innovative AI solution to improve the quality of patient treatment and increase department efficiency

Read more ››
By: PR Newswire Association LLC. - 21 Jan 2019

Breast Reconstruction Market to Touch US$ 1,358.7 Million by 2026, Says TMR

ALBANY, New York, January 21, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Jan 2019
Related companies:  Transparency Market Research

Visiongain Report Offers Transformative Insights on $15bn Defibrillators Market

LONDON, January 21, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Jan 2019

Presentation of Clearside Biomedical’s Extension Study of PEACHTREE for XIPERE™ Exhibits Durability Following Second Dose

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jan 2019
Related companies:  Clearside Biomedical, Inc.

Therap's Disability Software Offers Family Members Access to Relevant Individual Health Information

WATERBURY, Conn., Jan. 20, 2019 /PRNewswire/ -- Therap's role-based access provides secure health information that can be extended to designated agency personnel and external stakeholders, including self-advocates and family members. Allowing stakeholders access based on their role promotes efficiency... Read more ››

By: PR Newswire Association LLC. - 20 Jan 2019

Therap's Mobile App Allows Instant Reporting and Point-of-Service Documentation in the Community

WATERBURY, Conn., Jan. 20, 2019 /PRNewswire/ -- Therap mobile app for Android and iOS enables support professionals working in the home or community to navigate service programs for the individual they support, and remotely document outcomes and service data. Providers can enter progress notes,... Read more ››

By: PR Newswire Association LLC. - 20 Jan 2019

Media Advisory: Top Smoking Cessation Experts Meet in Ottawa

Read more ››
By: Nasdaq / GlobenewsWire - 19 Jan 2019
Related companies:  University of Ottawa Heart Institute

Study Helps Pharmaceutical Industry Navigate Shifting Landscape of Combination Product Development

CHAPEL HILL, N.C., Jan. 18, 2019 /PRNewswire/ -- The pharma industry recognizes the potential value of attacking complex diseases such as cancer through new therapies that utilize combinations of FDA-approved products.

Read more ››
By: PR Newswire Association LLC. - 19 Jan 2019

Testosterone Replacement Therapy In New Jersey Offered By Healthy Aging Medical Centers

WEST ORANGE, N.J., Jan. 18, 2019 /PRNewswire/ -- Healthy Aging Medical Centers is pleased to announce it now... Read more ››

By: PR Newswire Association LLC. - 19 Jan 2019

Lilly Phase 3 REACH-2 Trial Data Published in The Lancet Oncology Shows Improvement in Overall Survival with CYRAMZA® (ramucirumab) in Second-Line AFP-High Hepatocellular Carcinoma Patients

INDIANAPOLIS, Jan. 18, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced that results from the global Phase 3 REACH-2 study of CYRAMZA(®) (ramucirumab) as a single agent in the second-line treatment of people with AFP-High (alpha-fetoprotein >=400 ng/mL) hepatocellular carcinoma... Read more ››

By: PR Newswire Association LLC. - 19 Jan 2019
Related companies:  Eli Lilly and Company

CorVel Announces Promotion of Michael Combs to Chief Executive Officer

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  Avivagen Inc.

AVROBIO, Inc. Announces Acceptance of Investigational New Drug (IND) Application for Investigator-Sponsored Phase 1/2 Clinical Trial for AVR-RD-04 Gene Therapy for Cystinosis

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  Avrobio Inc.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑